$10.21
1.8321.84%
Last update: Dec 15, 3:40 PM
Comments
Loading...
FibroGen Insider Trading Activity | NASDAQ:FGEN | Benzinga
Track the latest FibroGen insider trading activity. Stay informed on recent buys, sells, and market impact for FibroGen stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are FibroGen Inc Insiders Doing?
At FibroGen Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 3.70K shares for a total value of $33.75K.
Notable Recent Insider Buys and Sales
- On November 17, 2025, Thane Wettig, the company's CEO purchased 3.7K shares for $9.12 each.
Ownership Statistics for FibroGen Inc
Shares Outstanding
4.045M
Insider Shares Owned
6.024M
Insider Percentage Owned
5.96%
Institutional Shares Held
606.987K
Institutional Percentage Held
9.07%
| Nov 17, 2025 | Thane Wettig | CEO | 3.70K | $9.12 | $33.75K | BUY | 17.39% | 24.98K | Nov 13 - Nov 17 | View |
| Jul 02, 2025 | James Schoeneck | — | 23.57K | $5.07 | $119.48K | BUY | 146.39% | 39.67K | Jun 30 | View |
| Mar 25, 2025 | Thane Wettig | CEO | 145.00K | $0.35 | $50.66K | BUY | 36.31% | 544.33K | Mar 24 | View |
| Mar 24, 2025 | James Schoeneck | — | 300.00K | $0.35 | $105.04K | BUY | 292.72% | 402.49K | Mar 20 - Mar 21 | View |
| Jun 13, 2024 | Deyaa Adib | CHIEF MEDICAL OFFICER | 22.12K | $1.17 | $25.88K | BUY | 36.87% | 82.12K | Jun 12 | View |
| Mar 11, 2024 | Thane Wettig | CEO | 50.00K | $1.91 | $95.47K | BUY | 11.87% | 471.18K | Mar 07 | View |
| Sep 06, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $1.03 | -$2.06K | SELL | -6.48% | 28.87K | Sep 01 | View |
| Aug 08, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $1.91 | -$3.82K | SELL | -6.09% | 30.87K | Aug 04 | View |
| Jul 13, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $2.69 | -$5.38K | SELL | -5.74% | 32.87K | Jul 11 | View |
| Jul 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.88K | $2.80 | -$5.26K | SELL | -0.46% | 402.52K | Jul 07 | View |
| Jun 26, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -791.00 | $16.53 | -$13.07K | SELL | -0.73% | 108.26K | Jun 23 | View |
| Jun 15, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -12.50K | $17.19 | -$214.93K | SELL | -5.02% | 236.33K | Jun 13 - Jun 14 | View |
| Jun 09, 2023 | Benjamin Cravatt | DIRECTOR | 4.34K | $17.17 | -$67.72K | GRANT | 17.81% | 28.74K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Aoife Brennan | DIRECTOR | 3.56K | $17.19 | -$81.37K | GRANT | 14.58% | 27.95K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Suzanne Blaug | DIRECTOR | -231.00 | $17.20 | -$146.57K | SELL | -0.77% | 29.59K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Maykin Ho | DIRECTOR | -231.00 | $17.44 | -$148.59K | SELL | -0.73% | 31.50K | Jun 07 - Jun 08 | View |
| Jun 09, 2023 | JEFFREY EDWARDS | DIRECTOR | 400.00 | $17.19 | -$135.62K | GRANT | 1.19% | 33.98K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | William Jeffrey Henderson | DIRECTOR | 1.29K | $17.46 | -$122.19K | GRANT | 3.84% | 34.87K | Jun 07 - Jun 08 | View |
| Jun 09, 2023 | James Schoeneck | DIRECTOR | 1.19K | $18.03 | -$127.99K | GRANT | 1.64% | 73.72K | Jun 07 | View |
| Jun 09, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -1.76K | $17.04 | -$29.95K | SELL | -1.55% | 111.39K | Jun 07 | View |
| Jun 09, 2023 | Juan Graham | CHIEF FINANCIAL OFFICER | -1.78K | $16.99 | -$30.32K | SELL | -2.45% | 71.08K | Jun 07 | View |
| Jun 09, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -3.63K | $17.04 | -$61.89K | SELL | -1.44% | 248.83K | Jun 07 | View |
| Jun 09, 2023 | Mark Eisner | EVP, CHIEF MEDICAL OFFICER | -2.04K | $17.04 | -$34.79K | SELL | -1.24% | 162.86K | Jun 07 | View |
| Jun 09, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -8.90K | $17.04 | -$151.58K | SELL | -2.15% | 404.40K | Jun 07 | View |
| Jun 05, 2023 | Mark Eisner | EVP, CHIEF MEDICAL OFFICER | -1.09K | $18.83 | -$20.52K | SELL | -0.66% | 164.90K | Jun 02 | View |
| Apr 11, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.87K | $19.52 | -$36.48K | SELL | -0.45% | 410.80K | Apr 10 | View |
| Apr 06, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | -9.18K | $18.78 | -$172.47K | SELL | -5.24% | 165.99K | Apr 04 | View |
| Apr 06, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -6.59K | $18.78 | -$123.79K | SELL | -2.54% | 252.46K | Apr 04 | View |
| Mar 24, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -905.00 | $18.71 | -$16.93K | SELL | -0.81% | 110.65K | Mar 23 | View |
| Mar 10, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -823.00 | $20.70 | -$330.36K | SELL | -0.32% | 259.05K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | 4.09K | $20.62 | -$1.16M | GRANT | 1.00% | 412.67K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | 2.68K | $20.60 | -$360.57K | GRANT | 1.55% | 175.18K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Juan Graham | CHIEF FINANCIAL OFFICER | -94.00 | $20.54 | -$157.37K | SELL | -0.13% | 72.87K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | 1.20K | $20.63 | -$287.43K | GRANT | 1.09% | 111.56K | Mar 08 - Mar 10 | View |
| Mar 06, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | -1.19K | $21.87 | -$25.96K | SELL | -0.68% | 172.50K | Mar 02 | View |
| Jan 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.54K | $19.95 | -$30.68K | SELL | -0.47% | 323.28K | Jan 06 | View |
| Dec 28, 2022 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -734.00 | $15.80 | -$11.60K | SELL | -0.82% | 89.16K | Dec 23 | View |
| Dec 15, 2022 | Juan Graham | CHIEF FINANCIAL OFFICER | -5.74K | $14.89 | -$85.50K | SELL | -10.27% | 50.15K | Dec 08 | View |
| Dec 14, 2022 | Juan Graham | CHIEF FINANCIAL OFFICER | -2.19K | $14.64 | -$32.04K | SELL | -3.91% | 53.70K | Dec 09 - Dec 12 | View |
| Dec 09, 2022 | Christine Chung | SVP, CHINA OPERATIONS | -1.10K | $15.79 | -$17.31K | SELL | -0.46% | 237.71K | Dec 08 | View |
| Dec 09, 2022 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -382.00 | $15.79 | -$6.03K | SELL | -0.42% | 89.90K | Dec 08 | View |
| Dec 09, 2022 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -2.54K | $15.79 | -$40.15K | SELL | -0.78% | 324.82K | Dec 08 | View |
| Sep 17, 2021 | THOMAS KEARNS JR | DIRECTOR | -13.10K | $11.58 | -$151.71K | SELL | -8.57% | 139.76K | Sep 15 | View |
| Aug 30, 2021 | Thane Wettig | CHIEF COMMERCIAL OFFICER | 3.10K | $11.53 | $35.74K | BUY | 6.78% | 48.82K | Aug 26 | View |
| Jun 17, 2021 | Pat Cotroneo | SVP, FINANCE AND CFO | -4.05K | $25.62 | -$103.84K | SELL | -1.44% | 276.68K | Jun 15 | View |
| Mar 15, 2021 | THOMAS KEARNS JR | DIRECTOR | 0.00 | $19.26 | -$567.36K | SELL-OPTIONS | 0.00% | 258.16K | Mar 11 | View |
| Feb 19, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $40.52 | -$142.48K | SELL-OPTIONS | 0.00% | 33.10K | Feb 17 | View |
| Jan 21, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $31.22 | -$145.98K | SELL-OPTIONS | 0.00% | 33.10K | Jan 19 | View |
| Jan 15, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $29.55 | -$125.92K | SELL-OPTIONS | 0.00% | 33.10K | Jan 14 | View |
| Dec 30, 2020 | Kalevi Kurkijarvi | — | 0.00 | $29.37 | -$132.40K | OPTION EXERCISE | 0.00% | 33.10K | Dec 28 | View |
| Dec 17, 2020 | Peony Yu | — | -3.35K | $41.61 | -$139.39K | SELL | -1.71% | 192.29K | Dec 16 | View |
| Dec 17, 2020 | Pat Cotroneo | — | -3.07K | $43.60 | -$133.76K | SELL | -1.14% | 266.14K | Dec 15 | View |
| Sep 18, 2020 | Peony Yu | — | -3.35K | $44.01 | -$147.48K | SELL | -1.66% | 198.93K | Sep 16 | View |
| Sep 17, 2020 | Pat Cotroneo | — | -3.07K | $43.63 | -$133.94K | SELL | -1.12% | 272.23K | Sep 15 | View |
| Sep 04, 2020 | Peony Yu | — | 0.00 | $34.45 | -$328.90K | OPTION EXERCISE | 0.00% | 205.58K | Sep 03 | View |
| Sep 04, 2020 | Pat Cotroneo | — | 0.00 | $37.10 | -$414.27K | OPTION EXERCISE | 0.00% | 278.31K | Sep 03 | View |
| Aug 11, 2020 | Pat Cotroneo | — | 7.25K | $33.61 | -$509.56K | OPTION EXERCISE | 2.67% | 278.31K | Aug 07 - Aug 11 | View |
| Jul 28, 2020 | Peony Yu | — | -3.35K | $42.35 | -$141.91K | SELL | -1.60% | 205.58K | Jul 24 | View |
| Jun 18, 2020 | Pat Cotroneo | — | -3.93K | $39.68 | -$155.86K | SELL | -1.43% | 271.06K | Jun 16 | View |
| Jun 12, 2020 | Enrique Conterno | — | 27.80K | $35.57 | $988.88K | PURCHASE | 46.33% | 87.80K | Jun 10 - Jun 11 | View |
| Mar 23, 2020 | THOMAS KEARNS JR | — | 0.00 | $13.04 | -$364.87K | OPTION EXERCISE | 0.00% | 253.46K | Mar 19 | View |
| Mar 19, 2020 | Christine Chung | — | 26.37K | $28.82 | -$492.46K | GRANT OR AWARD | 19.88% | 159.01K | Mar 06 - Mar 19 | View |
| Mar 18, 2020 | Pat Cotroneo | — | 25.88K | $30.97 | -$437.36K | GRANT OR AWARD | 10.33% | 276.47K | Mar 06 - Mar 17 | View |
| Feb 13, 2020 | Christine Chung | — | 0.00 | $35.31 | -$223.07K | OPTION EXERCISE | 0.00% | 132.64K | Feb 11 - Feb 12 | View |
| Feb 12, 2020 | Kalevi Kurkijarvi | — | 0.00 | $30.52 | -$146.10K | OPTION EXERCISE | 0.00% | 28.40K | Feb 10 | View |
| Jan 08, 2020 | Kalevi Kurkijarvi | — | 0.00 | $30.33 | -$147.96K | OPTION EXERCISE | 0.00% | 28.40K | Jan 06 | View |
| Jan 08, 2020 | Christine Chung | — | 0.00 | $34.13 | -$196.54K | OPTION EXERCISE | 0.00% | 132.64K | Jan 06 - Jan 07 | View |
| Dec 26, 2019 | Pat Cotroneo | SVP, FINANCE AND CFO | -3.20K | $26.74 | -$2.28M | SELL | -1.26% | 250.59K | Dec 20 | View |
| Dec 18, 2019 | Christine Chung | SVP, CHINA OPERATIONS | -3.50K | $36.21 | -$332.35K | SELL | -2.57% | 132.64K | Dec 16 - Dec 17 | View |
| Dec 17, 2019 | Peony Yu | CHIEF MEDICAL OFFICER | -3.42K | $46.68 | -$159.65K | SELL | -1.94% | 172.62K | Dec 16 | View |
| Dec 12, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $32.75 | -$177.00K | SELL-OPTIONS | 0.00% | 28.40K | Dec 09 | View |
| Nov 15, 2019 | Christine Chung | SVP, CHINA OPERATIONS | 0.00 | $27.63 | -$157.82K | SELL-OPTIONS | 0.00% | 139.63K | Nov 13 - Nov 14 | View |
| Nov 08, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $24.02 | -$170.97K | SELL-OPTIONS | 0.00% | 28.40K | Nov 07 | View |
| Oct 10, 2019 | Christine Chung | SVP, CHINA OPERATIONS | 0.00 | $28.04 | -$194.54K | SELL-OPTIONS | 0.00% | 139.63K | Oct 08 - Oct 09 | View |
| Oct 09, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $23.25 | -$161.73K | SELL-OPTIONS | 0.00% | 28.40K | Oct 07 | View |
| Sep 23, 2019 | Christine Chung | SVP, CHINA OPERATIONS | -3.50K | $29.78 | -$301.64K | SELL | -2.45% | 139.63K | Sep 19 - Sep 20 | View |
| Sep 18, 2019 | Peony Yu | CHIEF MEDICAL OFFICER | -3.42K | $40.92 | -$139.91K | SELL | -1.91% | 175.24K | Sep 16 | View |
| Sep 18, 2019 | Pat Cotroneo | SVP, FINANCE AND CFO | -3.20K | $41.38 | -$132.46K | SELL | -1.29% | 244.43K | Sep 17 | View |
| Sep 10, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $23.45 | -$210.02K | SELL-OPTIONS | 0.00% | 28.40K | Sep 09 | View |
| Aug 26, 2019 | Christine Chung | SVP, CHINA OPERATIONS | 0.00 | $31.28 | -$267.54K | SELL-OPTIONS | 0.00% | 151.57K | Aug 22 - Aug 23 | View |
| Aug 23, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $23.61 | -$1.72M | SELL | -19.80% | 105.18K | Aug 21 - Aug 22 | View |
| Aug 14, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $24.17 | -$1.76M | SELL | -19.38% | 108.02K | Aug 12 - Aug 13 | View |
| Aug 07, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $24.36 | -$250.32K | SELL-OPTIONS | 0.00% | 28.40K | Aug 05 | View |
| Jul 26, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $24.82 | -$1.81M | SELL | -18.98% | 110.86K | Jul 24 - Jul 25 | View |
| Jul 12, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $23.94 | -$1.74M | SELL | -18.59% | 113.69K | Jul 10 - Jul 11 | View |
| Jul 12, 2019 | Christine Chung | SVP, CHINA OPERATIONS | 0.00 | $36.95 | -$180.37K | SELL-OPTIONS | 0.00% | 151.57K | Jul 10 - Jul 11 | View |
| Jul 10, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $23.05 | -$234.57K | SELL-OPTIONS | 0.00% | 28.40K | Jul 08 | View |
| Jul 02, 2019 | Elias Kouchakji | SVP, CLINICAL DEV, DRUG SAFETY | -2.87K | $45.00 | -$129.28K | SELL | -2.56% | 109.20K | Jun 28 | View |
| Jun 21, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $23.55 | -$1.71M | SELL | -18.22% | 116.53K | Jun 19 - Jun 20 | View |
| Jun 20, 2019 | Pat Cotroneo | SVP, FINANCE AND CFO | -3.20K | $43.12 | -$138.03K | SELL | -1.26% | 250.78K | Jun 18 | View |
| Jun 20, 2019 | Christine Chung | SVP, CHINA OPERATIONS | -3.50K | $36.85 | -$265.85K | SELL | -2.26% | 151.57K | Jun 18 - Jun 19 | View |
| Jun 14, 2019 | Peony Yu | CHIEF MEDICAL OFFICER | 7.28K | $27.77 | $15.84K | SELL-OPTIONS | 4.05% | 186.98K | Jun 12 - Jun 14 | View |
| Jun 07, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -34.51K | $20.56 | -$1.80M | SELL | -22.43% | 119.36K | Jun 05 - Jun 06 | View |
| Jun 07, 2019 | Kalevi Kurkijarvi | DIRECTOR | 4.70K | $20.38 | -$209.74K | SELL-OPTIONS | 19.83% | 28.40K | Jun 05 - Jun 06 | View |
| May 24, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $19.14 | -$1.36M | SELL | -17.53% | 122.20K | May 22 - May 23 | View |
| May 15, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $19.62 | -$1.40M | SELL | -17.20% | 125.04K | May 13 - May 14 | View |
| May 10, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $24.42 | -$258.22K | SELL-OPTIONS | 0.00% | 23.70K | May 08 | View |
| May 09, 2019 | Christine Chung | SVP, CHINA OPERATIONS | 0.00 | $38.03 | -$188.40K | SELL-OPTIONS | 0.00% | 157.94K | May 07 - May 08 | View |
| May 09, 2019 | James Schoeneck | DIRECTOR | 0.00 | $24.96 | -$88.25K | SELL-OPTIONS | 0.00% | 27.70K | May 07 | View |
| Apr 19, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $24.83 | -$1.81M | SELL | -16.88% | 127.87K | Apr 17 - Apr 18 | View |
| Apr 17, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $25.50 | -$180.76K | SELL-OPTIONS | 0.00% | 23.70K | Apr 15 | View |
| Apr 10, 2019 | James Schoeneck | DIRECTOR | 0.00 | $27.90 | -$100.00K | SELL-OPTIONS | 0.00% | 27.70K | Apr 08 | View |
| Apr 10, 2019 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $27.97 | -$200.52K | SELL-OPTIONS | 0.00% | 23.70K | Apr 08 | View |
| Apr 05, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $28.49 | -$2.10M | SELL | -16.57% | 130.71K | Apr 03 - Apr 04 | View |
| Mar 22, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $29.21 | -$2.16M | SELL | -16.28% | 133.54K | Mar 20 - Mar 21 | View |
| Mar 20, 2019 | Pat Cotroneo | SVP, FINANCE AND CFO | -7.67K | $55.41 | -$424.72K | SELL | -3.10% | 239.50K | Mar 19 | View |
| Mar 15, 2019 | Peony Yu | CHIEF MEDICAL OFFICER | -9.14K | $56.30 | -$514.86K | SELL | -4.77% | 182.44K | Mar 14 | View |
| Mar 08, 2019 | James Schoeneck | DIRECTOR | 0.00 | $28.82 | -$103.67K | SELL-OPTIONS | 0.00% | 27.70K | Mar 07 | View |
| Mar 08, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -25.97K | $29.28 | -$2.17M | SELL | -16.00% | 136.38K | Mar 06 - Mar 07 | View |
| Mar 01, 2019 | Pat Cotroneo | SVP, FINANCE AND CFO | 0.00 | $44.87 | -$449.81K | SELL-OPTIONS | 0.00% | 253.10K | Feb 28 | View |
| Feb 21, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $30.50 | -$2.20M | SELL | -12.01% | 139.22K | Feb 19 - Feb 20 | View |
| Feb 08, 2019 | James Schoeneck | DIRECTOR | 0.00 | $30.04 | -$108.54K | SELL-OPTIONS | 0.00% | 27.70K | Feb 07 | View |
| Feb 08, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.54K | $30.03 | -$2.65M | SELL | -16.34% | 141.05K | Feb 07 - Feb 08 | View |
| Jan 24, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -39.36K | $27.80 | -$3.05M | SELL | -21.20% | 146.30K | Jan 22 - Jan 23 | View |
| Jan 09, 2019 | James Schoeneck | DIRECTOR | 0.00 | $24.40 | -$86.00K | SELL-OPTIONS | 0.00% | 27.70K | Jan 07 | View |
| Jan 07, 2019 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.09K | $24.00 | -$2.48M | SELL | -0.34% | 2.67M | Jan 03 - Jan 04 | View |
| Dec 21, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $25.39 | -$31.23K | SELL-OPTIONS | 0.00% | 32.70K | Dec 20 | View |
| Dec 21, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $22.11 | -$153.69K | SELL-OPTIONS | 0.00% | 23.70K | Dec 19 | View |
| Dec 20, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | -3.33K | $41.10 | -$136.86K | SELL | -1.48% | 222.00K | Dec 18 | View |
| Dec 18, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | -3.42K | $38.58 | -$132.02K | SELL | -2.32% | 144.12K | Dec 14 | View |
| Dec 06, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.66K | $22.35 | -$1.55M | SELL | -15.71% | 148.40K | Dec 03 - Dec 06 | View |
| Nov 21, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $21.48 | -$1.49M | SELL | -11.23% | 150.23K | Nov 20 - Nov 21 | View |
| Nov 16, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $24.51 | -$29.46K | SELL-OPTIONS | 0.00% | 32.70K | Nov 15 | View |
| Nov 16, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $21.34 | -$147.49K | SELL-OPTIONS | 0.00% | 23.70K | Nov 15 | View |
| Nov 02, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $23.96 | -$1.68M | SELL | -11.11% | 152.07K | Nov 01 - Nov 02 | View |
| Oct 19, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $32.58 | -$45.61K | SELL-OPTIONS | 0.00% | 32.70K | Oct 18 | View |
| Oct 19, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $29.16 | -$210.07K | SELL-OPTIONS | 0.00% | 23.70K | Oct 18 | View |
| Oct 19, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $28.91 | -$2.07M | SELL | -10.99% | 153.90K | Oct 18 - Oct 19 | View |
| Oct 04, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $31.37 | -$2.27M | SELL | -10.87% | 155.74K | Oct 02 - Oct 03 | View |
| Sep 21, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $33.36 | -$47.17K | SELL-OPTIONS | 0.00% | 32.70K | Sep 20 | View |
| Sep 21, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $30.70 | -$2.22M | SELL | -10.76% | 157.58K | Sep 19 - Sep 20 | View |
| Sep 18, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $30.88 | -$223.86K | SELL-OPTIONS | 0.00% | 23.70K | Sep 17 | View |
| Sep 14, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | 8.18K | $31.20 | -$107.47K | SELL-OPTIONS | 3.71% | 228.60K | Sep 12 - Sep 13 | View |
| Sep 12, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | -1.01K | $57.35 | -$57.98K | SELL | -0.46% | 220.42K | Sep 10 | View |
| Sep 12, 2018 | Jorma Routti | DIRECTOR | 0.00 | $37.82 | -$233.80K | SELL-OPTIONS | 0.00% | 131.54K | Sep 10 | View |
| Sep 07, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $30.56 | -$2.21M | SELL | -10.65% | 159.41K | Sep 06 - Sep 07 | View |
| Aug 24, 2018 | Toshinari Tamura | DIRECTOR | 0.00 | $39.85 | -$499.20K | SELL-OPTIONS | 0.00% | 51.70K | Aug 22 | View |
| Aug 22, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $31.92 | -$2.31M | SELL | -10.54% | 161.25K | Aug 20 - Aug 21 | View |
| Aug 17, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $35.03 | -$50.50K | SELL-OPTIONS | 0.00% | 32.70K | Aug 16 | View |
| Aug 17, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $31.59 | -$229.53K | SELL-OPTIONS | 0.00% | 23.70K | Aug 16 | View |
| Aug 10, 2018 | Jorma Routti | DIRECTOR | 0.00 | $38.96 | -$251.58K | SELL-OPTIONS | 0.00% | 131.54K | Aug 09 | View |
| Aug 03, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $33.30 | -$2.42M | SELL | -10.43% | 163.08K | Aug 01 - Aug 02 | View |
| Jul 20, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $37.34 | -$55.13K | SELL-OPTIONS | 0.00% | 32.70K | Jul 19 | View |
| Jul 20, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $34.26 | -$2.50M | SELL | -10.33% | 164.92K | Jul 18 - Jul 19 | View |
| Jul 20, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $33.63 | -$245.80K | SELL-OPTIONS | 0.00% | 23.70K | Jul 19 | View |
| Jul 11, 2018 | Jorma Routti | DIRECTOR | 0.00 | $42.85 | -$298.26K | SELL-OPTIONS | 0.00% | 131.54K | Jul 09 | View |
| Jul 06, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | 0.00 | $39.79 | -$788.90K | SELL-OPTIONS | 0.00% | 147.47K | Jul 03 | View |
| Jul 06, 2018 | James Schoeneck | DIRECTOR | 0.00 | $33.95 | -$474.38K | SELL-OPTIONS | 0.00% | 3.70K | Jul 03 | View |
| Jul 06, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $34.29 | -$2.50M | SELL | -10.23% | 166.76K | Jul 05 - Jul 06 | View |
| Jun 26, 2018 | James Schoeneck | DIRECTOR | 0.00 | $33.95 | -$270.82K | SELL-OPTIONS | 0.00% | 3.70K | Jun 22 | View |
| Jun 22, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $36.71 | -$53.88K | SELL-OPTIONS | 0.00% | 32.70K | Jun 21 | View |
| Jun 22, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $33.61 | -$2.45M | SELL | -10.13% | 168.59K | Jun 20 - Jun 21 | View |
| Jun 20, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $30.54 | -$221.16K | SELL-OPTIONS | 0.00% | 23.70K | Jun 18 | View |
| Jun 15, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | -3.42K | $59.20 | -$202.58K | SELL | -2.27% | 147.47K | Jun 14 | View |
| Jun 15, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | -2.32K | $42.44 | -$401.96K | SELL | -1.02% | 224.70K | Jun 13 - Jun 14 | View |
| Jun 12, 2018 | Jorma Routti | DIRECTOR | 0.00 | $33.63 | -$286.23K | SELL-OPTIONS | 0.00% | 131.54K | Jun 11 | View |
| Jun 08, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | -3.29K | $56.28 | -$185.04K | SELL | -1.43% | 227.02K | Jun 06 - Jun 08 | View |
| Jun 05, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -21.28K | $29.21 | -$2.22M | SELL | -11.10% | 170.43K | Jun 01 - Jun 05 | View |
| Jun 05, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | -993.00 | $37.20 | -$268.76K | SELL | -0.43% | 230.31K | Jun 01 - Jun 04 | View |
| May 23, 2018 | Pat Cotroneo | SVP, FINANCE AND CFO | 0.00 | $38.62 | -$492.22K | SELL-OPTIONS | 0.00% | 231.30K | May 21 | View |
| May 18, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $30.99 | -$42.42K | SELL-OPTIONS | 0.00% | 29.00K | May 17 | View |
| May 18, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $27.71 | -$1.98M | SELL | -9.93% | 172.26K | May 16 - May 17 | View |
| May 18, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $27.36 | -$195.72K | SELL-OPTIONS | 0.00% | 20.00K | May 17 | View |
| May 11, 2018 | Jorma Routti | DIRECTOR | 0.00 | $28.44 | -$223.95K | SELL-OPTIONS | 0.00% | 127.84K | May 09 | View |
| May 04, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $25.32 | -$1.79M | SELL | -9.84% | 174.10K | May 02 - May 03 | View |
| Apr 20, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $28.74 | -$37.92K | SELL-OPTIONS | 0.00% | 29.00K | Apr 19 | View |
| Apr 20, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $25.29 | -$179.16K | SELL-OPTIONS | 0.00% | 20.00K | Apr 19 | View |
| Apr 19, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $26.08 | -$1.85M | SELL | -9.74% | 175.94K | Apr 17 - Apr 18 | View |
| Apr 18, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | -7.50K | $47.81 | -$358.55K | SELL | -4.68% | 152.83K | Apr 16 | View |
| Apr 11, 2018 | Jorma Routti | DIRECTOR | 0.00 | $26.27 | -$243.85K | SELL-OPTIONS | 0.00% | 127.84K | Apr 09 | View |
| Apr 06, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.00K | $24.59 | -$1.73M | SELL | -9.65% | 177.77K | Apr 04 - Apr 05 | View |
| Mar 22, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -21.55K | $27.28 | -$1.95M | SELL | -10.71% | 179.61K | Mar 20 - Mar 21 | View |
| Mar 16, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | 22.11K | $53.20 | -$526.20K | GRANT | 16.00% | 160.33K | Mar 14 | View |
| Mar 16, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $31.06 | -$42.56K | SELL-OPTIONS | 0.00% | 29.00K | Mar 15 | View |
| Mar 16, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $27.67 | -$198.16K | SELL-OPTIONS | 0.00% | 20.00K | Mar 15 | View |
| Mar 15, 2018 | Toshinari Tamura | DIRECTOR | 0.00 | $35.77 | -$844.82K | SELL-OPTIONS | 0.00% | 48.00K | Mar 13 | View |
| Mar 15, 2018 | Pat Cotroneo | VP, FINANCE AND CFO | 22.07K | $39.26 | -$1.29M | SELL-OPTIONS | 12.66% | 196.33K | Mar 14 - Mar 15 | View |
| Mar 14, 2018 | RORY RIGGS | DIRECTOR | -32.09K | $54.66 | -$1.75M | SELL | -3.16% | 984.91K | Mar 12 - Mar 13 | View |
| Mar 13, 2018 | THOMAS KEARNS JR | DIRECTOR | -500.00 | $29.30 | -$925.20K | SELL | -0.20% | 245.06K | Mar 06 - Mar 12 | View |
| Mar 09, 2018 | RORY RIGGS | DIRECTOR | -22.91K | $55.75 | -$1.28M | SELL | -2.20% | 1.02M | Mar 09 | View |
| Mar 08, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -35.25K | $27.91 | -$2.92M | SELL | -16.27% | 181.44K | Mar 06 - Mar 08 | View |
| Mar 08, 2018 | Pat Cotroneo | VP, FINANCE AND CFO | -7.73K | $53.45 | -$412.92K | SELL | -4.25% | 174.27K | Mar 06 - Mar 08 | View |
| Feb 23, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -19.11K | $29.51 | -$2.20M | SELL | -9.44% | 183.28K | Feb 22 - Feb 23 | View |
| Feb 16, 2018 | Jorma Routti | DIRECTOR | 0.00 | $29.40 | -$621.57K | SELL-OPTIONS | 0.00% | 127.84K | Feb 14 - Feb 15 | View |
| Feb 16, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | 0.00 | $32.84 | -$46.12K | SELL-OPTIONS | 0.00% | 29.00K | Feb 15 | View |
| Feb 16, 2018 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $39.57 | -$1.62M | SELL-OPTIONS | 0.00% | 183.85K | Feb 15 - Feb 16 | View |
| Feb 16, 2018 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $29.29 | -$316.72K | SELL-OPTIONS | 0.00% | 20.00K | Feb 15 | View |
| Feb 09, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | -7.50K | $53.97 | -$404.78K | SELL | -4.93% | 144.59K | Feb 08 | View |
| Jan 31, 2018 | Peony Yu | CHIEF MEDICAL OFFICER | -10.00K | $62.00 | -$620.00K | SELL | -6.17% | 152.09K | Jan 29 | View |
| Jan 31, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $61.40 | -$2.37M | SELL | -21.19% | 143.67K | Jan 29 - Jan 30 | View |
| Jan 30, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | -6.00K | $60.00 | -$360.00K | SELL | -17.14% | 29.00K | Jan 26 | View |
| Jan 24, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | -2.00K | $50.00 | -$100.00K | SELL | -5.41% | 35.00K | Jan 22 - Jan 23 | View |
| Jan 24, 2018 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $33.36 | -$767.95K | SELL-OPTIONS | 0.00% | 183.85K | Jan 22 | View |
| Jan 19, 2018 | Pedro Roberto Rosenkranz | DIRECTOR | -5.00K | $28.61 | -$274.92K | SELL | -11.90% | 37.00K | Jan 18 | View |
| Jan 19, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $47.46 | -$1.83M | SELL | -21.10% | 144.51K | Jan 18 - Jan 19 | View |
| Jan 19, 2018 | Kalevi Kurkijarvi | DIRECTOR | -12.00K | $25.14 | -$301.67K | SELL | -35.29% | 22.00K | Jan 18 | View |
| Jan 08, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $47.61 | -$1.84M | SELL | -21.00% | 145.34K | Jan 04 - Jan 05 | View |
| Jan 02, 2018 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -39.64K | $48.39 | -$1.87M | SELL | -17.44% | 187.62K | Dec 15 - Dec 29 | View |
| Dec 22, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | 41.36K | $23.96 | -$1.47M | SELL-OPTIONS | 28.12% | 188.46K | Dec 20 - Dec 21 | View |
| Dec 19, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $42.80 | -$85.60K | SELL | -8.33% | 22.00K | Dec 18 | View |
| Dec 15, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -2.85K | $43.70 | -$124.59K | SELL | -1.73% | 162.09K | Dec 14 | View |
| Dec 15, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $42.19 | -$1.63M | SELL | -16.95% | 189.30K | Dec 14 - Dec 15 | View |
| Dec 13, 2017 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $23.68 | -$498.60K | SELL-OPTIONS | 0.00% | 24.00K | Dec 12 | View |
| Dec 13, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | -2.85K | $46.00 | -$131.15K | SELL | -1.53% | 183.85K | Dec 11 | View |
| Dec 05, 2017 | Gerald Lema | DIRECTOR | 3.50K | $46.70 | $163.45K | BUY | ∞ | 3.50K | Dec 04 | View |
| Dec 04, 2017 | Jorma Routti | DIRECTOR | 0.00 | $25.07 | -$532.20K | SELL-OPTIONS | 0.00% | 127.84K | Nov 30 - Dec 01 | View |
| Nov 20, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $46.65 | -$93.30K | SELL | -7.69% | 24.00K | Nov 17 | View |
| Nov 17, 2017 | THOMAS KEARNS JR | DIRECTOR | 0.00 | $23.79 | -$771.66K | SELL-OPTIONS | 0.00% | 248.56K | Nov 15 | View |
| Nov 17, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $46.63 | -$1.80M | SELL | -16.89% | 190.13K | Nov 16 - Nov 17 | View |
| Nov 08, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -7.50K | $55.37 | -$415.24K | SELL | -4.27% | 168.05K | Nov 06 | View |
| Nov 01, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $56.13 | -$2.17M | SELL | -16.83% | 190.97K | Oct 30 - Oct 31 | View |
| Oct 18, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $52.24 | -$104.48K | SELL | -7.14% | 26.00K | Oct 17 | View |
| Oct 18, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $55.02 | -$2.13M | SELL | -16.77% | 191.80K | Oct 16 - Oct 17 | View |
| Oct 06, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | 0.00 | $37.29 | -$681.38K | SELL-OPTIONS | 0.00% | 175.55K | Oct 04 | View |
| Oct 04, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -10.00K | $34.60 | -$1.75M | SELL | -5.39% | 175.55K | Oct 02 | View |
| Oct 04, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $55.09 | -$2.13M | SELL | -16.71% | 192.64K | Oct 02 - Oct 03 | View |
| Sep 21, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $53.46 | -$2.07M | SELL | -16.65% | 193.47K | Sep 19 - Sep 20 | View |
| Sep 20, 2017 | Kalevi Kurkijarvi | DIRECTOR | -4.00K | $46.65 | -$186.58K | SELL | -12.50% | 28.00K | Aug 17 - Sep 18 | View |
| Sep 15, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -2.85K | $51.00 | -$145.40K | SELL | -1.51% | 185.55K | Sep 14 | View |
| Sep 15, 2017 | RORY RIGGS | DIRECTOR | -25.00K | $51.92 | -$1.30M | SELL | -2.35% | 1.04M | Sep 13 | View |
| Sep 15, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -38.64K | $51.67 | -$2.00M | SELL | -16.59% | 194.31K | Sep 13 - Sep 14 | View |
| Sep 13, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | -2.85K | $49.45 | -$140.98K | SELL | -1.78% | 157.41K | Sep 11 | View |
| Sep 05, 2017 | Jorma Routti | DIRECTOR | 0.00 | $25.48 | -$525.06K | SELL-OPTIONS | 0.00% | 127.84K | Aug 31 - Sep 01 | View |
| Aug 30, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -2.21K | $23.04 | -$1.60M | SELL | -1.12% | 195.15K | Aug 28 - Aug 29 | View |
| Aug 23, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -7.50K | $41.03 | -$307.73K | SELL | -3.77% | 191.51K | Aug 21 | View |
| Aug 10, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -17.50K | $32.58 | -$1.61M | SELL | -8.08% | 199.01K | Aug 08 | View |
| Aug 10, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $32.01 | -$3.53M | SELL-OPTIONS | 0.00% | 163.37K | Aug 08 | View |
| Aug 03, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | 0.00 | $24.03 | -$189.05K | SELL-OPTIONS | 0.00% | 216.51K | Aug 01 | View |
| Aug 03, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $20.44 | -$766.98K | SELL-OPTIONS | 0.00% | 163.37K | Aug 01 - Aug 02 | View |
| Jul 26, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $18.72 | -$1.27M | SELL | -0.42% | 195.98K | Jul 24 - Jul 25 | View |
| Jul 18, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $33.45 | -$66.90K | SELL | -5.88% | 32.00K | Jul 17 | View |
| Jul 11, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -5.00K | $32.98 | -$164.90K | SELL | -2.26% | 216.51K | Jul 10 | View |
| Jul 07, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $17.86 | -$1.20M | SELL | -0.42% | 196.82K | Jul 06 - Jul 07 | View |
| Jul 07, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $18.45 | -$124.40K | SELL-OPTIONS | 0.00% | 163.37K | Jul 06 | View |
| Jun 23, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $17.45 | -$87.30K | SELL-OPTIONS | 0.00% | 163.37K | Jun 22 | View |
| Jun 23, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $16.93 | -$1.13M | SELL | -0.42% | 197.66K | Jun 21 - Jun 22 | View |
| Jun 21, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $16.18 | -$152.07K | SELL-OPTIONS | 0.00% | 163.37K | Jun 19 | View |
| Jun 19, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $28.50 | -$57.00K | SELL | -5.56% | 34.00K | Jun 15 | View |
| Jun 19, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.05K | $15.87 | -$1.06M | SELL | -3.90% | 198.49K | Jun 15 - Jun 16 | View |
| Jun 16, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -3.72K | $28.95 | -$107.72K | SELL | -1.65% | 221.51K | Jun 14 | View |
| Jun 14, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | -2.89K | $28.75 | -$83.12K | SELL | -1.74% | 163.37K | Jun 12 | View |
| Jun 13, 2017 | Toshinari Tamura | DIRECTOR | 0.00 | $17.69 | -$671.55K | SELL-OPTIONS | 0.00% | 48.00K | Jun 09 - Jun 12 | View |
| Jun 08, 2017 | THOMAS KEARNS JR | DIRECTOR | 0.00 | $19.24 | -$340.83K | SELL-OPTIONS | 0.00% | 248.56K | Jun 06 | View |
| Jun 01, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -5.53K | $14.35 | -$1.05M | SELL | -0.16% | 3.38M | May 30 - Jun 01 | View |
| May 17, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $27.40 | -$54.80K | SELL | -5.26% | 36.00K | May 16 | View |
| May 17, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $15.02 | -$981.23K | SELL | -0.42% | 200.16K | May 15 - May 16 | View |
| May 12, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -5.00K | $26.38 | -$131.89K | SELL | -2.16% | 226.05K | May 10 | View |
| Apr 27, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | 0.00 | $21.29 | -$67.13K | SELL-OPTIONS | 0.00% | 231.05K | Apr 25 | View |
| Apr 27, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $15.18 | -$166.72K | SELL-OPTIONS | 0.00% | 157.91K | Apr 25 | View |
| Apr 26, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $15.25 | -$904.98K | SELL | -0.41% | 201.00K | Apr 24 - Apr 25 | View |
| Apr 19, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $25.25 | -$50.50K | SELL | -5.00% | 38.00K | Apr 17 | View |
| Apr 14, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $14.41 | -$805.53K | SELL | -0.41% | 201.84K | Apr 12 - Apr 13 | View |
| Apr 04, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $13.97 | -$771.98K | SELL | -0.41% | 202.67K | Apr 03 - Apr 04 | View |
| Mar 22, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $14.18 | -$788.16K | SELL | -0.41% | 203.51K | Mar 20 - Mar 21 | View |
| Mar 16, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -7.85K | $25.41 | -$199.46K | SELL | -3.29% | 231.05K | Mar 14 | View |
| Mar 16, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -16.92K | $14.55 | -$881.06K | SELL | -7.65% | 204.34K | Mar 14 - Mar 15 | View |
| Mar 14, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | -7.85K | $25.30 | -$198.63K | SELL | -4.74% | 157.91K | Mar 10 | View |
| Mar 06, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $14.18 | -$153.72K | SELL-OPTIONS | 0.00% | 132.25K | Mar 01 - Mar 02 | View |
| Feb 17, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $24.45 | -$48.90K | SELL | -4.76% | 40.00K | Feb 16 | View |
| Feb 15, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -836.00 | $13.98 | -$772.62K | SELL | -0.41% | 205.18K | Feb 13 - Feb 14 | View |
| Feb 10, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $13.74 | -$773.31K | SELL | -0.29% | 3.32M | Feb 08 - Feb 09 | View |
| Jan 27, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $13.66 | -$766.88K | SELL | -0.29% | 3.33M | Jan 26 - Jan 27 | View |
| Jan 20, 2017 | Kalevi Kurkijarvi | DIRECTOR | -2.00K | $24.90 | -$49.80K | SELL | -4.55% | 42.00K | Jan 19 | View |
| Jan 13, 2017 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $13.18 | -$140.72K | SELL-OPTIONS | 0.00% | 132.25K | Jan 11 | View |
| Jan 13, 2017 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $13.94 | -$788.09K | SELL | -0.29% | 3.34M | Jan 11 - Jan 12 | View |
| Jan 12, 2017 | Peony Yu | CHIEF MEDICAL OFFICER | -5.00K | $23.56 | -$117.80K | SELL | -2.41% | 202.45K | Jan 10 | View |
| Dec 29, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $12.38 | -$670.51K | SELL | -0.29% | 3.34M | Dec 27 - Dec 28 | View |
| Dec 16, 2016 | RORY RIGGS | DIRECTOR | -20.00K | $20.87 | -$417.31K | SELL | -1.84% | 1.07M | Dec 16 | View |
| Dec 16, 2016 | Peony Yu | CHIEF MEDICAL OFFICER | -2.34K | $20.65 | -$48.40K | SELL | -1.12% | 207.45K | Dec 14 | View |
| Dec 14, 2016 | Pat Cotroneo | VP, FINANCE AND CFO | -2.34K | $22.05 | -$51.69K | SELL | -1.74% | 132.25K | Dec 12 | View |
| Dec 14, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $12.63 | -$689.40K | SELL | -0.29% | 3.35M | Dec 12 - Dec 13 | View |
| Nov 30, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $13.41 | -$748.36K | SELL | -0.28% | 3.37M | Nov 28 - Nov 29 | View |
| Nov 18, 2016 | THOMAS KEARNS JR | DIRECTOR | 0.00 | $13.21 | -$330.71K | SELL-OPTIONS | 0.00% | 270.56K | Nov 17 - Nov 18 | View |
| Nov 18, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $13.16 | -$729.08K | SELL | -0.28% | 3.38M | Nov 16 - Nov 17 | View |
| Nov 01, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $10.39 | -$519.87K | SELL | -0.28% | 3.39M | Oct 31 - Nov 01 | View |
| Oct 19, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $10.89 | -$557.48K | SELL | -0.28% | 3.40M | Oct 18 - Oct 19 | View |
| Oct 05, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $12.32 | -$665.58K | SELL | -0.28% | 3.41M | Oct 03 - Oct 04 | View |
| Sep 22, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $12.84 | -$705.27K | SELL | -0.28% | 3.42M | Sep 20 - Sep 21 | View |
| Sep 15, 2016 | Peony Yu | CHIEF MEDICAL OFFICER | -2.35K | $18.66 | -$43.76K | SELL | -1.12% | 206.50K | Sep 14 | View |
| Sep 14, 2016 | Pat Cotroneo | VP, FINANCE AND CFO | -2.35K | $18.22 | -$42.73K | SELL | -1.72% | 134.36K | Sep 12 | View |
| Sep 09, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $11.50 | -$604.16K | SELL | -0.28% | 3.43M | Sep 08 - Sep 09 | View |
| Aug 29, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $10.91 | -$559.27K | SELL | -0.28% | 3.44M | Aug 25 - Aug 26 | View |
| Jul 28, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -9.62K | $11.20 | -$581.12K | SELL | -0.28% | 3.45M | Jul 26 - Jul 27 | View |
| Jul 14, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $17.50 | -$472.42K | SELL | -0.77% | 3.46M | Jul 12 - Jul 13 | View |
| Jun 30, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $16.02 | -$432.57K | SELL | -0.77% | 3.49M | Jun 28 - Jun 29 | View |
| Jun 16, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $16.48 | -$444.96K | SELL | -0.76% | 3.51M | Jun 14 - Jun 15 | View |
| Jun 16, 2016 | Pat Cotroneo | VP, FINANCE AND CFO | -1.80K | $16.49 | -$29.62K | SELL | -1.28% | 138.11K | Jun 15 | View |
| Jun 14, 2016 | Peony Yu | CHIEF MEDICAL OFFICER | -2.34K | $17.96 | -$42.10K | SELL | -1.10% | 210.26K | Jun 10 | View |
| Jun 03, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -31.69K | $18.97 | -$601.17K | SELL | -0.89% | 3.54M | Jun 01 - Jun 03 | View |
| May 20, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $17.68 | -$477.42K | SELL | -0.75% | 3.57M | May 19 - May 20 | View |
| May 18, 2016 | Peony Yu | CHIEF MEDICAL OFFICER | -6.11K | $17.60 | -$107.48K | SELL | -2.77% | 214.01K | May 16 | View |
| May 18, 2016 | Pat Cotroneo | VP, FINANCE AND CFO | -6.11K | $17.60 | -$107.48K | SELL | -4.13% | 141.87K | May 16 | View |
| May 03, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $17.78 | -$480.06K | SELL | -0.74% | 3.60M | May 02 - May 03 | View |
| Apr 20, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $19.98 | -$539.46K | SELL | -0.74% | 3.63M | Apr 19 - Apr 20 | View |
| Apr 05, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $21.11 | -$570.04K | SELL | -0.73% | 3.65M | Apr 04 - Apr 05 | View |
| Apr 04, 2016 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $12.52 | -$184.75K | SELL-OPTIONS | 0.00% | 108.68K | Apr 01 | View |
| Mar 22, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $18.74 | -$505.87K | SELL | -0.73% | 3.68M | Mar 21 - Mar 22 | View |
| Mar 08, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $19.62 | -$529.61K | SELL | -0.72% | 3.71M | Mar 07 - Mar 08 | View |
| Mar 03, 2016 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $10.23 | -$142.15K | SELL-OPTIONS | 0.00% | 112.61K | Mar 01 | View |
| Feb 24, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | 73.00K | $19.11 | -$515.85K | GRANT | 1.99% | 3.74M | Feb 22 - Feb 23 | View |
| Feb 18, 2016 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $10.89 | -$161.81K | SELL-OPTIONS | 0.00% | 100.84K | Feb 16 | View |
| Feb 11, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $15.31 | -$413.36K | SELL | -0.73% | 3.67M | Feb 09 - Feb 10 | View |
| Jan 29, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $19.41 | -$524.01K | SELL | -0.72% | 3.70M | Jan 28 - Jan 29 | View |
| Jan 22, 2016 | THOMAS KEARNS JR | DIRECTOR | -1.57K | $22.08 | -$34.71K | SELL | -0.58% | 270.56K | Jan 21 | View |
| Jan 15, 2016 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $23.69 | -$639.68K | SELL | -0.72% | 3.72M | Jan 13 - Jan 14 | View |
| Dec 28, 2015 | THOMAS KEARNS JR | DIRECTOR | -7.80K | $30.88 | -$240.82K | SELL | -2.79% | 272.14K | Dec 23 - Dec 24 | View |
| Dec 23, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $30.10 | -$812.70K | SELL | -0.71% | 3.75M | Dec 22 - Dec 23 | View |
| Dec 17, 2015 | Pat Cotroneo | VP, FINANCE AND CFO | -837.00 | $28.95 | -$24.23K | SELL | -0.77% | 107.33K | Dec 15 | View |
| Dec 11, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -1.09K | $28.96 | -$31.65K | SELL | -0.62% | 176.59K | Dec 10 | View |
| Dec 11, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $29.59 | -$798.82K | SELL | -0.71% | 3.78M | Dec 10 - Dec 11 | View |
| Dec 10, 2015 | MIGUEL MADERO | DIRECTOR | 43.61K | $18.98 | -$604.13K | SELL-OPTIONS | 11.43% | 425.25K | Dec 08 | View |
| Nov 30, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.00K | $30.00 | -$150.00K | SELL | -2.73% | 178.34K | Nov 25 - Nov 30 | View |
| Nov 30, 2015 | Pat Cotroneo | VP, FINANCE AND CFO | 0.00 | $16.18 | -$138.25K | SELL-OPTIONS | 0.00% | 107.78K | Nov 25 | View |
| Nov 25, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $28.49 | -$769.13K | SELL | -0.70% | 3.81M | Nov 23 - Nov 24 | View |
| Nov 25, 2015 | THOMAS KEARNS JR | DIRECTOR | -7.80K | $28.51 | -$222.39K | SELL | -2.71% | 279.94K | Nov 23 - Nov 24 | View |
| Nov 18, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.00K | $28.00 | -$140.00K | SELL | -2.65% | 183.34K | Nov 17 | View |
| Nov 10, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.00K | $25.61 | -$128.07K | SELL | -2.59% | 187.90K | Nov 09 - Nov 10 | View |
| Nov 04, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $13.04 | -$202.79K | SELL-OPTIONS | 0.00% | 84.04K | Nov 02 | View |
| Oct 30, 2015 | Thomas B Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $24.06 | -$649.55K | SELL | -0.70% | 3.83M | Oct 29 - Oct 30 | View |
| Oct 22, 2015 | THOMAS KEARNS JR | DIRECTOR | -7.80K | $23.83 | -$185.90K | SELL | -2.64% | 287.74K | Oct 20 - Oct 21 | View |
| Oct 21, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $12.68 | -$206.50K | SELL-OPTIONS | 0.00% | 84.04K | Oct 19 | View |
| Oct 21, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.00K | $24.00 | -$120.00K | SELL | -2.53% | 192.90K | Oct 19 | View |
| Oct 16, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $21.86 | -$590.15K | SELL | -0.69% | 3.86M | Oct 15 - Oct 16 | View |
| Oct 16, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.00K | $21.46 | -$107.30K | SELL | -2.46% | 197.90K | Oct 15 - Oct 16 | View |
| Oct 02, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -27.00K | $21.59 | -$583.06K | SELL | -0.69% | 3.89M | Oct 01 - Oct 02 | View |
| Oct 02, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $11.86 | -$190.28K | SELL-OPTIONS | 0.00% | 84.04K | Oct 01 | View |
| Sep 18, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.06K | $15.98 | -$731.54K | SELL | -0.21% | 3.92M | Sep 17 - Sep 18 | View |
| Sep 15, 2015 | RORY RIGGS | DIRECTOR | -50.00K | $27.61 | -$1.38M | SELL | -4.40% | 1.09M | Sep 11 - Sep 14 | View |
| Sep 15, 2015 | MIGUEL MADERO | DIRECTOR | -20.60K | $27.66 | -$569.80K | SELL | -5.12% | 381.63K | Sep 11 | View |
| Sep 15, 2015 | Pat Cotroneo | VP, FINANCE AND CFO | 247.00 | $15.42 | -$26.66K | SELL-OPTIONS | 0.23% | 107.50K | Sep 11 - Sep 15 | View |
| Sep 14, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -1.09K | $27.84 | -$30.43K | SELL | -0.54% | 202.90K | Sep 10 | View |
| Sep 10, 2015 | Pat Cotroneo | VP, FINANCE AND CFO | 690.00 | $14.86 | -$185.37K | SELL-OPTIONS | 0.65% | 107.25K | Sep 08 - Sep 10 | View |
| Sep 04, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -4.03K | $12.62 | -$286.63K | SELL | -0.10% | 3.92M | Sep 04 | View |
| Sep 03, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | -704.00 | $12.94 | -$228.36K | SELL | -0.83% | 84.04K | Sep 01 | View |
| Sep 03, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -6.31K | $12.63 | -$339.23K | SELL | -0.16% | 3.93M | Sep 01 - Sep 03 | View |
| Aug 07, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.06K | $12.83 | -$585.13K | SELL | -0.20% | 3.93M | Aug 05 - Aug 06 | View |
| Aug 05, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $12.86 | -$210.23K | SELL-OPTIONS | 0.00% | 84.75K | Aug 03 | View |
| Jul 24, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.06K | $13.53 | -$622.67K | SELL | -0.20% | 3.94M | Jul 22 - Jul 23 | View |
| Jul 21, 2015 | MD FRANK VALONE | CHIEF MEDICAL OFFICER | 0.00 | $13.03 | -$21.35K | SELL-OPTIONS | 0.00% | 84.75K | Jul 20 | View |
| Jul 21, 2015 | Pat Cotroneo | VP, FINANCE AND CFO | -5.38K | $12.91 | -$179.13K | SELL | -4.84% | 105.82K | Jul 17 - Jul 20 | View |
| Jul 10, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.06K | $12.23 | -$552.33K | SELL | -0.20% | 3.95M | Jul 08 - Jul 09 | View |
| Jul 07, 2015 | Peony Yu | VP, CLINICAL DEVELOPMENT | -5.38K | $22.69 | -$122.10K | SELL | -2.56% | 204.65K | Jul 06 | View |
| Jun 26, 2015 | Thomas Neff | CHIEF EXECUTIVE OFFICER | -8.06K | $12.96 | -$591.82K | SELL | -0.20% | 3.96M | Jun 24 - Jun 25 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
FGEN Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved